Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 4351 - 4375 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU01
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260964 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC01
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260988 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ01
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • galgactosyl-paraglobside(d18:1/16:0)
44261252 1388.802768 C66H120N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BK01
  • Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261260 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AN01
  • Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261916 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AS01
  • Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • iGb5(d18:1/16:0)
44261580 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AU01
  • Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261596 1388.802768 C66H120N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BE01
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261660 1388.802768 C66H120N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AU03
  • Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260326 1387.843904 C68H125NO27
Glycosyldiacylglycerols LMGL05010071
  • 1-(9Z-octadecenoyl)-2-(9,10-methylene-octadecanoic acid)-3-O-beta-d-glucopyranosyl-(1->6)-alpha-d-galactopyranosyl-(6-(9Z-octadecenoyl))-(1->2)-alpha-d-glucosyl-sn-glycerol
  • 1-oleoyl-2-Dihydrosterculoyl-3-O-beta-d-glucopyranosyl-(1->6)-alpha-d-galactopyranosyl-(6-(9Z-octadecenoyl))-(1->2)-alpha-d-glucosyl-sn-glycerol
171118824 1384.957415 C76H136O21
Gangliosides LMSP0601AM02
  • GM2(d18:1/18:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262061 60327 1383.823837 C67H121N3O26
Gangliosides LMSP0601EK02
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262829 1383.823837 C67H121N3O26
Monoacylglycerophosphoinositolglycans LMGP15040033
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM5(16:0/0:0)
126457690 1382.560293 C55H99O37P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN05
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260592 1379.901692 C70H129N3O23
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN07
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260594 1377.886042 C70H127N3O23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM02
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260261 1375.807519 C66H121NO28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260548 1372.807853 C66H120N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC01
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lewis a(d18:1/16:0)
44260628 1372.807853 C66H120N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD01
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type I H antigen(d18:1/16:0)
44260636 1372.807853 C66H120N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB01
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lex-5(d18:1/16:0)
44260980 1372.807853 C66H120N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD01
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type II antigen(d18:1/16:0)
44260996 1372.807853 C66H120N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV01
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261604 1372.807853 C66H120N2O27
Gangliosides LMSP0601CI01
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
52931289 1371.787452 C65H117N3O27
Gangliosides LMSP0601DC03
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262574 1370.828588 C67H122N2O26
Gangliosides LMSP0601DG03
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • KDN-GM2(d18:1/20:0)
44262606 1370.828588 C67H122N2O26

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024